ApoB/apoA-I ratio is related to femoral artery plaques in 64-year-old women also in cases with low LDL cholesterol

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 817-822

  Schmidt, C ^a   Fagerberg, B ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Apolipoproteins; Carotid arteries; Femoral artery; Intima media thickness; Plaques; Ultrasonography

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CAROTID ARTERIES; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; MIDDLE AGED; RISK; TUNICA INTIMA; WAIST-HIP RATIO;

EID: 38349125656     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.01.017     Document Type: Article

References (23)

1. Wallenfeldt K., Bokemark L., Wikstrand J., et al. Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men. Stroke 35 (2004) 2248-2252
2. Walldius G., and Jungner I. The apoB/apoA-I ratio: a strong new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med 259 (2006) 493-519
3. Walldius G., and Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets of lipid-modifying therapy. J Intern Med 255 (2004) 188-205
4. Duprez D.A., and Cohn J.N. Monitoring vascular health beyond blood pressure. Curr Hypertens Rep 4 (2006) 287-291
5. Lonn E. Carotid intima-media thickness-a new non-invasive gold standard for assessing the anatomic extent of atherosclerosis and cardiovascular risk?. Clin Invest Med 22 (1999) 158-160
6. Wendelhag I., Wiklund O., and Wikstrand J. On quantifying plaque size in carotid and femoral arteries. Comments on results from a prospective study in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 16 (1996) 843-850
7. Jadhav U.M., and Kadam N.N. Apolipoproteins: correlation with carotid intima media thickness and coronary artery disease. J Assoc Physician India 52 (2004) 370-375
8. Snehalatha C., Vijay V., Suresh M.R., et al. Lack of association of insulin resistance and carotid intimal medial thickness in non-diabetic Asian Indian subjects. Diabetes Metab Res Rev 17 (2001) 444-447
9. Schott L.L., Wildman R.P., Brockwell S., et al. Segment-specific effects of cardiovascular risk factors on carotid artery intima-medial thickness in women at midlife. Arterioscler Thromb Vasc Biol 24 (2004) 1951-1956
10. Schmidt C., Fagerberg B., Wikstrand J., et al. ApoB/apoA-I is related to femoral artery plaques and is predictive for future cardiovascular events in healthy men. Atherosclerosis 189 (2006) 178-185
11. Brohall G., Behre C.J., Hulthe J., et al. Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care 29 (2006) 363-367
12. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus; 1999.
13. Wendelhag I., Wiklund O., and Wikstrand J. Atherosclerosic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Atheroscler Thromb 13 (1993) 1404-1411
14. Schmidt C., and Wendelhag I. How can the variability in ultrasound measurement of intima-media thickness be reduced? Studies of interobserver variability in carotid and femoral arteries. Clin Physiol 19 (1999) 45-55
15. Hulthe J., Wikstrand J., and Fagerberg B. Relationship between C-reactive protein and intima-media thickness in the carotid and femoral arteries and to antibodies against oxidized low-density lipoprotein in healthy men: the atherosclerosis and insulin resistance (AIR) study. Clin Sci 100 (2001) 371-378
16. Walldius G., Jungner I., Aastveit A.H., et al. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk. Clin Chem Lab Med 42 (2004) 1355-1363
17. Walldius G., and Jungner I. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J 26 (2005) 210-212
18. Joensuu T., Salonen R., Winblad I., et al. Determinants of femoral and carotid artery atherosclerosis. J Intern Med 236 (1994) 79-84
19. van den Berkmortel F.W.P.J., van der Steen M., Hoogenboom H., et al. Progressive arterial wall stiffening in patients with increasing diastolic blood pressure. J Hum Hypertens 15 (2001) 685-691
20. Kawakami A., and Yoshida M. Remnant lipoproteins and atherosclerosis. J Atheroscler Thromb 12 (2005) 73-76
21. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham heart study. Atherosclerosis 154 (2001) 229-236
22. Wallenfeldt K., Hulthe J., Bokemark L., et al. Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking 58-year-old men. J Intern Med 250 (2001) 492-501
23. Danese C., Vestri A.R., D́Alfonso V., et al. Do hypertension and diabetes mellitus influence the site of atherosclerotic plaques?. Clin Ter 157 (2006) 9-13